PA
AVO icon

PharVision Advisers’s Mission Produce AVO Stock Holding History

PharVision Advisers’s Portfolio AVO Stock Details AVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,560
Closed -$412K – 146
2025
Q4 		$412K Buy
35,560
+18,107
+104% +$217K 0.21% 109
2025
Q3 		$210K Buy
+17,453
New +$215K 0.12% 479
2025
Q1 		– Sell
-20,137
Closed -$289K – 287
2024
Q4 		$289K Buy
+20,137
New +$260K 0.24% 170

Other funds holding AVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $660M AUM 27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $2.18B AUM 30.3% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PharVision Advisers's AVO Position: Q1 2026 in Review

PharVision Advisers sold out of Mission Produce (AVO) in Q1 2026, closing a stake of 35,560 shares — an estimated $412K sold.

PharVision Advisers first reported a position in AVO in Q4 2024 and held it in 3 quarters. The position peaked at $412K in Q4 2025. 171 funds tracked by Wall St. Rank hold AVO as of Q1 2026.

  • PharVision Advisers reported no remaining Mission Produce position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 35,560 Mission Produce shares in Q1 2026, an estimated $412K.
  • PharVision Advisers first reported a position in Mission Produce in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Mission Produce position peaked at $412K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Mission Produce as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.